| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.035 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.03 | 0.9 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |